Alexander Epshinsky - 22 Jan 2025 Form 4 Insider Report for Allarity Therapeutics, Inc. (ALLR)

Reporting relationship: CFO
Issuer ticker: ALLR
Reported as of: 22 Jan 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Jan 2025, 16:17:24 UTC
Prior SEC filing: 18 Sep 2024
Source filing: View source filing
Reporting owner signature: /s/ Alexander Epshinsky

Key filing fact

Alexander Epshinsky filed Form 4 for Allarity Therapeutics, Inc. (ALLR) on 24 Jan 2025.

Key facts

This page summarizes Alexander Epshinsky's Form 4 filing for Allarity Therapeutics, Inc. (ALLR).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 24 Jan 2025, 16:17.

Change

Previous filing in this sequence was filed on 18 Sep 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALLR transaction

Common Stock

Award

Transaction value: $0
Shares: +29,496
Change %: +53%
Price: $0.000000
Shares after: 85,051
Date: 22 Jan 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The restricted stock units, or RSUs, granted on January 22, 2025 pursuant to Allarity Therapeutics, Inc's Amended and Restated 2021 Equity Incentive Plan, will vest in equal one-third installments on the first, second, and third anniversary of the grant, subject to the Reporting Person's continued relationship with the Issuer through each such date.